WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the 2nd quarter and half year ended on 30th September, 2024
Welcure Drugs And Pharmaceuticals Ltd. Press Release Nov 07 2024
Filed with BSE · · 1 page · English
Release
Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Welcure Drugs and Pharmaceuticals
- Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Oct 23 2024
- Welcure Drugs and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Newspaper Publication
Later from Welcure Drugs and Pharmaceuticals
- Board Meeting Intimation for Postponement Of Board Meeting
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Nov 13 2024
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals LimitedHeld On Today I.E. Thursday, 14Th November, 2024.
- Unaudited Financial Results Of The Company Along With TheLimited Review Report As Issued By Statutory Auditor Of The Company For The 2Nd Quarter And HalfYear Ended On 30Th September 2024.
- Submission Of Half Yearly Disclosures On Related Party Transactions For A Period From 1St April, 2024 To 30Th September, 2024
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals